P. Pichat

发表

Effect of mizolastine on visceral sensory afferent sensitivity and inflammation during experimental colitis.

N. Roome, I. Angel, S. Arbilla, 1998, Arzneimittel-Forschung.

Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.

I. Angel, S. Arbilla, P. Pichat, 1998, Arzneimittel-Forschung.

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

G. Griebel, J. Stemmelin, O. Bergis, 2007, Neuropsychopharmacology.

The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents

G. Griebel, J. Stemmelin, O. Bergis, 2018, Scientific Reports.

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

I. Weiner, G. Griebel, D. Boulay, 2008, Psychopharmacology.

Synthesis and biological evaluation of analogues of M6G.

Y. Troin, P. George, I. Ripoche, 2011, European journal of medicinal chemistry.

The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia

G. Griebel, D. Boulay, O. Bergis, 2016, Scientific Reports.

The psychopharmacology of GABA synapses: update 1989.

B. Scatton, P. Morselli, K. Lloyd, 1990, Journal of neural transmission. Supplementum.

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents

G. Griebel, J. Stemmelin, D. Boulay, 2019, Scientific Reports.

Mice Deficient in Cryptochrome 1 (Cry1−/−) Exhibit Resistance to Obesity Induced by a High-Fat Diet

G. Griebel, S. Beeské, P. Avenet, 2014, Front. Endocrinol..

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

G. Griebel, J. Stemmelin, D. Boulay, 2008, Pharmacology Biochemistry and Behavior.

SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents

I. Weiner, G. Griebel, J. Terranova, 2012, Pharmacology Biochemistry and Behavior.

The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents

G. Griebel, J. Stemmelin, O. Bergis, 2018, Scientific Reports.

Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents

Thomas Bertrand, Bailin Zhang, Lionel Bert, 2015, Scientific Reports.

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

S. Stahl, G. Griebel, J. Stemmelin, 2008, Neuropsychopharmacology.

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

S. Stahl, G. Griebel, J. Stemmelin, 2008, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

The CRF1 receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis

G. Griebel, C. Belzung, R. Palme, 2012, Pharmacology Biochemistry and Behavior.

The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognition

G. Griebel, O. Bergis, C. Cohen, 2011, Pharmacology Biochemistry and Behavior.

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

I. Weiner, B. Borowsky, G. Griebel, 2011, Psychopharmacology.

GABA synapses, depression, and antidepressant drugs.

K. Lloyd, P. Pichat, 1987, Psychopharmacology series.

GABAB Receptors and Antidepressant Drugs

D. Sanger, K. Lloyd, P. Pichat, 1989 .

Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants.

P. Soubrié, A. Puech, J. Massol, 1989, Neuropsychobiology.

Acute inescapable stress exposure induces long-term sleep disturbances and avoidance behavior: A mouse model of post-traumatic stress disorder (PTSD)

G. Griebel, C. Belzung, S. Beeské, 2011, Behavioural Brain Research.

Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)phenyl] amide as histamine H(3) receptor antagonist for the treatment of depression.

Nicolas Moindrot, W. Hurst, P. George, 2013, Bioorganic & medicinal chemistry letters.

Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.

G. Griebel, W. Hurst, Lothar Schwink, 2013, Bioorganic & medicinal chemistry letters.

SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents

I. Weiner, G. Griebel, J. Terranova, 2012, Pharmacology Biochemistry and Behavior.